English < Article List - DigitalToday

Search results for SK Biopharm

AI & Enterprise

SK Telecom, SK Biopharm find early drug candidates for hard-to-treat cancer with AI

SK Telecom and SK Biopharm have discovered early-stage drug candidates that could be used to develop targeted therapies for hard-to-treat cancers using AI. The companies said they generated and selected binder candidates that can attach to ROR1, a tumour-related cell surface protein, and confirmed 2 early candidates through laboratory validation. The joint study took about 5 months and cut the early research period by more than 60 percent.

AI & Enterprise

Medical, bio AI models prove global competitiveness, move to phase two development

Two AI-focused foundation models being developed in South Korea for medical and bio applications will move into phase two after an interim performance review, the Ministry of Science and ICT said on Monday. A Lunit consortium and a KAIST consortium each scored above 80 points, meeting the 70-point threshold for further support. The ministry plans to keep providing each consortium with 256 Nvidia B200 GPUs through early September. The models are set to be released as open source in early April.